Characterisation of circulating biomarkers before and after cardiac resynchronisation therapy and their role in predicting CRT response: the COVERT-HF study

AIMS: Cardiac resynchronisation therapy (CRT) is effective treatment for selected patients with heart failure (HF) but has ~30% non-response rate. We evaluated whether specific biomarkers can predict outcome. METHODS: A prospective single-centre pilot study of consecutive unselected patients undergo...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Open Heart
Main Authors: McAloon, Christopher J, Barwari, Temo, Hu, Jimiao, Hamborg, Thomas, Nevill, Alan, Hyndman, Samantha, Ansell, Valerie, Musa, Anntoniette, Jones, Julie, Goodby, Julie, Banerjee, Prithwish, O’Hare, Paul, Mayr, Manuel, Randeva, Harpal, Osman, Faizel
Formato: Artigo
Idioma:Inglês
Publicado: BMJ Publishing Group 2018
Assuntos:
Heart Failure and Cardiomyopathies
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6196945/
https://ncbi.nlm.nih.gov/pubmed/30364565
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/openhrt-2018-000899
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares